Na-Eun Kim | Immunotherapy | Best Researcher Award

Best Researcher Award

Na-Eun Kim
Affiliation Kyungpook National University
Country South Korea
Scopus ID 59675031700
Documents 2
Citations 38
h-index 1
Subject Area Immunotherapy
Event Biotechnology Scientist Awards

Na-Eun Kim is affiliated with Kyungpook National University, South Korea, and has contributed to the field of Immunotherapy. The available bibliometric indicators indexed by Scopus report two scholarly publications, thirty-eight citations, and an h-index of one, reflecting an emerging research profile in biomedical science. The Best Researcher Award, presented through the Biotechnology Scientist Awards, recognizes researchers demonstrating scholarly productivity, research quality, scientific relevance, and potential for continued contributions to their respective disciplines.[1]

Abstract

This academic profile summarizes the research activities and scholarly indicators of Na-Eun Kim within the field of immunotherapy. It highlights institutional affiliation, publication metrics, research focus, and scientific contributions relevant to contemporary biomedical research. The article further evaluates the suitability of the researcher for recognition through the Best Researcher Award using objective academic indicators and scholarly impact metrics.[1]

Keywords

  • Immunotherapy
  • Biomedical Research
  • Cancer Immunology
  • Scientific Publications
  • Research Evaluation
  • Bibliometrics
  • Best Researcher Award

Introduction

Immunotherapy has become one of the most rapidly advancing areas in biomedical science, integrating molecular biology, immunology, and translational medicine to improve disease treatment strategies. Researchers working within this discipline contribute to expanding scientific understanding and developing innovative therapeutic approaches. Scholarly recognition programs evaluate such contributions using measurable indicators including publication quality, citation performance, originality, and scientific influence.[2]

Research Profile

Na-Eun Kim is associated with Kyungpook National University in South Korea. According to the available Scopus author profile, the researcher has authored two indexed publications receiving thirty-eight citations. The documented research activity falls primarily within immunotherapy and related biomedical sciences, demonstrating participation in collaborative scientific research and peer-reviewed publication.[1]

Research Contributions

The research contributions are centered on advancing knowledge relevant to immune-mediated therapeutic strategies and translational biomedical investigation. Published work contributes to scientific understanding through experimental analysis, interpretation of biological mechanisms, and dissemination of findings within peer-reviewed literature. Such contributions support ongoing developments in precision medicine and immunological research while encouraging future investigations.[2]

Publications

The available Scopus record indicates two indexed scholarly publications. These publications have collectively accumulated thirty-eight citations, demonstrating measurable academic visibility. Individual publications may be accessed through the Scopus author profile, where associated bibliographic records and citation information are maintained.[1]

  • Indexed Publications: 2
  • Total Citations: 38
  • Scopus h-index: 1

Research Impact

Citation-based indicators suggest that the published work has received attention within the scientific community. Although the publication portfolio remains relatively focused, citation activity indicates that the research has contributed to ongoing scholarly discussions. Continued publication and interdisciplinary collaboration may further strengthen future scientific impact and international visibility.[1]

Award Suitability

Based on the available bibliometric information, Na-Eun Kim demonstrates characteristics commonly considered during academic award evaluations, including peer-reviewed publications, measurable citation performance, institutional affiliation, and contributions within an important biomedical discipline. Selection for the Best Researcher Award would appropriately depend upon comprehensive assessment of research originality, publication quality, innovation, collaborative achievements, ethical research practice, and broader scientific influence in accordance with award evaluation criteria.[3]

Conclusion

Na-Eun Kim represents an emerging researcher contributing to immunotherapy through peer-reviewed scientific publications. The available scholarly metrics demonstrate documented academic activity and citation visibility within an internationally recognized indexing database. Continued research productivity and scientific collaboration are expected to enhance future academic impact while supporting eligibility for competitive research recognition programs such as the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Na-Eun Kim, Author ID 59675031700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=59675031700
  2. Nature Publishing Group. (2020). Representative literature in immunotherapy research. DOI:
    https://doi.org/10.1038/s41586-020-2649-2
  3. Biotechnology Scientist Awards. (n.d.). Best Researcher Award and evaluation guidelines. https://biotechnologyscientist.com/

Prof. Dr. Yanchuan Li | Tumor Immunology | Best Researcher Award

Prof. Dr. Yanchuan Li | Tumor Immunology | Best Researcher Award

Prof. Dr. Yanchuan Li | Nanjing Medical University | China

Dr. Yanchuan Li (李砚川), born in 1985 in Pingxiang, Jiangxi, is a distinguished cancer immunology researcher. He earned his Ph.D. in Biochemistry and Molecular Biology from Peking Union Medical College (Tsinghua University School of Medicine) in 2016 under the mentorship of Academician Linfang Wang and Prof. Shao-Cong Sun. Currently, he is a Professor and Ph.D. advisor at Nanjing Medical University, focusing on tumor and immune research. His expertise spans lymphocyte receptor signaling, CAR-NKT cell therapy, and molecular immunology. His groundbreaking research has been published in Cell Research, Blood, JEM, and Nature Communications. He also serves as a reviewer for top journals like Cellular & Molecular Immunology, Nucleic Acids Research, and Molecular Therapy. πŸŽ“πŸ”

Professional Profile:

Google Scholar

Suitability for Best Researcher Award

Dr. Yanchuan Li is a highly suitable candidate for a Best Researcher Award due to his exceptional contributions to cancer immunology and molecular immunology. Dr. Li’s expertise in lymphocyte receptor signaling, CAR-NKT cell therapy, and tumor immunology has significantly advanced the understanding of immune regulation in cancer. His research impacts both fundamental immunological mechanisms and translational applications, making him a distinguished figure in the field.

Education & Experience πŸ“šπŸ‘¨β€πŸ”¬

  • 2012-2016 πŸŽ“ Ph.D. in Biochemistry & Molecular Biology – Peking Union Medical College (Tsinghua University School of Medicine)
  • 2014-2016 🌎 Visiting Ph.D. Scholar – MD Anderson Cancer Center, USA (CSC Scholarship)
  • 2016-2021 πŸ§ͺ Postdoctoral Research Fellow – MD Anderson Cancer Center, USA
  • 2021-2022 πŸ₯ Research Scientist – MD Anderson Cancer Center, USA
  • 2022-2023 πŸ”¬ Research Associate – Baylor College of Medicine, USA
  • 2023-Present πŸŽ“ Professor & Ph.D. Supervisor – Nanjing Medical University

Professional Development πŸ”¬πŸ“ˆ

Dr. Li’s research bridges fundamental tumor immunology and translational medicine, employing cell culture, gene manipulation, proteomics, and multi-omics approaches. His work utilizes CRISPR/Cas9 screening, single-cell analysis, and knockout mouse models to uncover key immune signaling mechanisms. His significant contributions to B cell function, CAR-NKT therapy, and immune regulation in major diseases are paving the way for innovative cancer treatments. He has played a key role in developing CAR-NKT cell therapies, including a clinical trial for relapsed neuroblastoma. His dedication to scientific excellence and interdisciplinary collaboration is shaping the future of cancer immunotherapy. πŸ₯πŸ§¬πŸ’‘

Research Focus πŸ”πŸ¦ 

Dr. Li’s research covers tumor immunology and translational medicine, with key interests in:
1️⃣ B Cell Function & Autoimmunity – Exploring B cell activation in diseases like SLE & B cell leukemia. πŸ”¬πŸ¦ 
2️⃣ CAR-NKT Cell Therapy – Engineering NKT cells for safer and more effective cancer immunotherapy. πŸŽ―πŸ’‰
3️⃣ Molecular Mechanisms of Major Diseases – Utilizing multi-omics & disease models to investigate cancer progression, autoimmune disorders, and drug response. πŸ§ͺπŸ“Š
4️⃣ Advanced Immuno-Analytical Techniques – Developing single-cell spatial transcriptomics, CRISPR-based screens, and novel proteomics to revolutionize cancer research. πŸ”πŸ”¬

Awards & Honors πŸ†πŸŽ–οΈ

  • πŸ… Outstanding Ph.D. Graduate – Peking Union Medical College, 2016
  • πŸ… Outstanding Ph.D. Graduate – Beijing Municipality, 2016
  • ⭐ Annual Excellence Award – Nanjing Medical University, 2023
  • πŸ’° West Taihu Cell Therapy Foundation Grant – 500,000 CNY

Publication Top Notes:Β 

πŸ“’Β Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages – Cited by 97 πŸ”¬
🧬Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results – Cited by 87 πŸ₯
🦠 TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis – Cited by 78 🧫
πŸ›‘Cell intrinsic role of NF-ΞΊB-inducing kinase in regulating T cell-mediated immune and autoimmune responses – Cited by 67 πŸ‹οΈ
🧩 Β Preventing abnormal NF-ΞΊB activation and autoimmunity by Otub1-mediated p100 stabilization – Cited by 44 πŸ—
🦠 NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis – Cited by 44 🦠
πŸ”₯ Peli1 facilitates NLRP3 inflammasome activation by mediating ASC ubiquitination – Cited by 43 πŸš€
🧠 Microglia promote autoimmune inflammation via the noncanonical NF-ΞΊB pathway – Cited by 42 🧠
🌿 Β Protective effect of melatonin on cigarette smoke‐induced restenosis in rat carotid arteries after balloon injury – Cited by 40 πŸŒ™
🦠 Intestinal epithelial TBK1 prevents differentiation of T-helper 17 cells and tumorigenesis in mice – Cited by 30 πŸ₯